|
| 37963317 | Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. | J Clin Oncol | 2024 |
| 37963317 | Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. | J Clin Oncol | 2024 |
| 36848831 | Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. | Eur J Cancer | 2023 |
| 36883420 | Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM. | Int J Cancer | 2023 |
| 37382622 | A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma. | World J Urol | 2023 |
| 36848831 | Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. | Eur J Cancer | 2023 |
| 37382622 | A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma. | World J Urol | 2023 |
| 36883420 | Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM. | Int J Cancer | 2023 |
| 35274903 | Artificial intelligence to predict oncological outcome directly from hematoxylin and eosin-stained slides in urology. | Minerva Urol Nephrol | 2022 |
| 35709415 | FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group. | J Clin Oncol | 2022 |
| 35963849 | Functional antagonism between CagA and DLC1 in gastric cancer. | Cell Death Discov | 2022 |
| 36098320 | Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial. | Lancet Healthy Longev | 2022 |
| 36191839 | Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling. | J Mol Diagn | 2022 |
| 35781181 | Response to letter entitled: Re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review. | Eur J Cancer | 2022 |
| 35976907 | Deep learning can predict survival directly from histology in clear cell renal cell carcinoma. | PLoS One | 2022 |
| 36497358 | DNA-Methylation Analysis as a Tool for Thymoma Classification. | Cancers (Basel) | 2022 |
| 35274903 | Artificial intelligence to predict oncological outcome directly from hematoxylin and eosin-stained slides in urology. | Minerva Urol Nephrol | 2022 |
| 35709415 | FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group. | J Clin Oncol | 2022 |
| 35781181 | Response to letter entitled: Re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review. | Eur J Cancer | 2022 |
| 36497358 | DNA-Methylation Analysis as a Tool for Thymoma Classification. | Cancers (Basel) | 2022 |
| 35963849 | Functional antagonism between CagA and DLC1 in gastric cancer. | Cell Death Discov | 2022 |
| 36098320 | Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial. | Lancet Healthy Longev | 2022 |
| 36191839 | Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling. | J Mol Diagn | 2022 |
| 35976907 | Deep learning can predict survival directly from histology in clear cell renal cell carcinoma. | PLoS One | 2022 |
| 32776177 | Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system. | J Cancer Res Clin Oncol | 2021 |
| 33706408 | Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer. | BJU Int | 2021 |
| 33467055 | Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune Diseases. | Cancers (Basel) | 2021 |
| 34035403 | The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma. | Sci Rep | 2021 |
| 34134925 | High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer. | Urol Oncol | 2021 |
| 34026331 | PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells. | Oncoimmunology | 2021 |
| 33497701 | Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants. | Am J Pathol | 2021 |
| 34356494 | Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study. | Biology (Basel) | 2021 |
| 33318582 | Molecular characterization of ulcerative colitis-associated colorectal carcinomas. | Mod Pathol | 2021 |
| 32776177 | Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system. | J Cancer Res Clin Oncol | 2021 |
| 34497477 | GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study. | Pathol Oncol Res | 2021 |
| 34551034 | Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma. | J Gastrointestin Liver Dis | 2021 |
| 34941983 | Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence. | J Gastrointestin Liver Dis | 2021 |
| 34885060 | Changes in Methylation across Structural and MicroRNA Genes Relevant for Progression and Metastasis in Colorectal Cancer. | Cancers (Basel) | 2021 |
| 33706408 | Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer. | BJU Int | 2021 |
| 33497701 | Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants. | Am J Pathol | 2021 |
| 34885060 | Changes in Methylation across Structural and MicroRNA Genes Relevant for Progression and Metastasis in Colorectal Cancer. | Cancers (Basel) | 2021 |
| 34941983 | Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence. | J Gastrointestin Liver Dis | 2021 |
| 34497477 | GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study. | Pathol Oncol Res | 2021 |
| 34551034 | Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma. | J Gastrointestin Liver Dis | 2021 |
| 34035403 | The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma. | Sci Rep | 2021 |
| 34026331 | PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells. | Oncoimmunology | 2021 |
| 34356494 | Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study. | Biology (Basel) | 2021 |
| 34134925 | High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer. | Urol Oncol | 2021 |
| 33318582 | Molecular characterization of ulcerative colitis-associated colorectal carcinomas. | Mod Pathol | 2021 |
| 33467055 | Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune Diseases. | Cancers (Basel) | 2021 |